Figure 2From: The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patientsTissue expression of CXCL13 and CXCR5, and its correlation with GPS and stage. (A) Representative ENKTL case with negative CXCL13 staining (×400). (B) CXCR5 antibody stains the cytoplasm of ENKTL tumor cells and B-cells in a normal germinal center. (C) There were significantly more patients with high CXCL13 in the GPS 2 group than in the GPS 0 or 1 groups (P < 0.05). (D) More patients have high CXCL13 with stage III/IV disease than do patients with stage I/II (P < 0.05).Back to article page